Norgine announces £23 million new investment as part of more than £50 million committed to expanding medicines manufacturing in Wales
PR Newswire —
AMSTERDAM, March 5, 2026 /PRNewswire/ -- Norgine, a leading European specialty pharmaceutical company, today announced a new £23 million investment in its Hengoed, Wales manufacturing site bringing the total investment at the facility to more than £50 million since 2022. Supported by the...